We found that 15-prostaglandin dehydrogenase (15-PGDH), a rate-limiting enzyme that catalyzes the degradation of prostaglandin [27], is significantly down-regulated in CRC in cancer tissues compared to normal tissues. The gene discussed is HPGD; the disease is colorectal carcinoma.